Professional Documents
Culture Documents
0r"1
~2:J367~95" ~:625
::'z:e
c:
as
Business Strategy
Source
www.StrategyR.com
Transaction 420367195-19625
D9t~ deltvered: 7,119/2011
~Icensee' Ms Tornese
Company nstituto Naclor,al de Tecrl!1ologia Industnal
MCP-2039
1. INTRODUCTION,
METHODOLOGY
PRODUCT DEFINITIONS
.
Study Reliability
and Reporting
&
5. END-USE APPLICATIONS:
SPECTRUM
Limitations
Disclaimers.
..
Data Interpretation & Reporting Level..
Quantitative Techniques & Analytics
Product Deftnitions and Scope of Study........
..
..
..
Introduction to Biopolymers....
Chitin: A Modified Form of Glucose
..
2. INDUSTRY
OVERVIEW
2
3
3
3
A Primer
Current and Future Analysis
Chitosan Market by End-Use.
...5
... 5
...5
..
6
6
6
.6
..
for
.
4. PRODUCT OVERVIEW..
....... 6
........ 7
....... 7
..
Introduction to Biopolymers..
Applications of Biopolymers ....
Degradation: No more a Problem
Synthesis ofBiopolymers
Forms of Biopolymers..
Starch and Glucose..
...8
....... 8
.8
9
...9
.9
with Biopolymers.
Linear Biopolymers
Chitin and Chitosan: Most Common Form of Natural
Biopolymers
Chitin: A Modified Form of Glucose
Chitosan
Evolution of Chitin and Chitosan
Chitin and Chitosan at a Glance..
Features..
Solubility
.. 9
..
..
..
..
..
9
10
10
10
II
II
II
. II
.12
.. .... 12
.. 13
.13
Chitosan
Properties of Chitin and Chitosan
Chitin
.. I 3
13
13
Chitosan
Sources of Extraction.....
14
. 14
Chitin...
.. 14
General Applications....
Q~=...
Manufacturing
..
Process
17
4
4
..
A BROAD
15
15
16
16
.. 16
..
18
19
20
20
20
20
..
..
21
22
22
.. .. 22
..
..
23
23
24
24
..24
24
25
25
25
25
..
..
..
..
26
26
...26
..
26
27
27
27
27
27
27
..
..
..
.. .. 28
.. .. 28
...28
25
25
25
26
26
..
..
22
22
23
23
23
23
.23
28
28
..
Perfringens
...29
29
Spore
420:'67195. f 9625
Detede\'er!?fj' 719!20'"'
dcensee
Ms Torr,ese
Tra'1sactlon
Cop;pary.
lsdLl/.O Nacl('li2
oe Tec'""l110ioglc
""';:k.&.~.2
MCP-2039
..29
29
As a Fat Trapper..........................
Cleansing Digestive Tract.......
Reducing
... 29
29
..29
Agrochemicals...
Builds up Plant Immune System
Chitosan in Agrochemicals......
In Formulation of Pesticides
Carrier of Yeast Antagonists
Increases Crop Yield..
Health Care/Medical........
30
.. 30
... 30
30
30
.30
30
33
33
.. .. 33
.. .. 33
Drugs ..... 33
... 33
34
34
..
(US)
34
35
35
35
34
34
34
34
.. 35
35
35
35
..
.36
36
36
36
36
36
..
..
37
.. 37
.. 37
.37
.. .... 38
.. 38
..
38
39
39
Observations
Highlighting
Chitin Properties..
39
39
39
39
.40
.40
..
..
..
..
.40
....41
41
.41
.. .4 J
.41
42
Derived Chitosan
Proteins
Paclitaxel-Incorporated
Tumor Growth
Chitosan
42
43
.. .43
43
.. .. 43
43
44
.. 44
44
....44
44
Hydrogel
.45
.45
in Release of Disease
.
42
.
.
Inhibits
.
.....45
....45
...46
MCP-2039
Develops
46
46
.
and
... 47
Unveils KiOnutrime-Cs
and KiOnutrime-CG
47
47
..47
... 48
.
48
......... 48
48
8. PRODUCT INNOVATIONS/LAUNCHES
IN
RECENT PAST-A PERSPECTIVE
BU]LDER
.49
Shiseido Develops
Health Perception
Hyaluronic
Launches
Acid Molecule.
GlucOsamax
Extra
49
.... 49
..49
Supplement
49
Reintroduces
Valupak
MatsyaFed
Chitosan
Commences
Capsules.....
..50
51
..51
52
ACTIVITY
Commercial
Manufacturing
of
.
52
52
52
52
Agency
Divests ChitiNor
to Seagarden
Navamedic
Navamedic
Navamedic
55
55
PAST-
56
.56
.56
.56
58
..
..
..
58
58
58
.. 59
..
59
59
...60
60
60
.. 60
... 61
..
..
61
.....61
50
9. RECENT INDUSTRY
50
50
50
Navamedic
Selects SanguiBioTech's
.
Hydrochloride
Biodegradable
.... 53
53
.
.
54
54
54
54
55
.. 62
....63
64
...65
Transaction
D8t
420367195-19625
,jeli\tered"
Licensee
Company.
7/19/2011
Ms Tornese
Instltuto Naclona'
de Ted';1ologla
induslr,a
MCP-2039
.. 70
71
72
77
83
TransaC,tOn~20367195-19625
DC'te 'Jeitvere.J 7119/2011
rSdfUlO 'aclonaJ
ae TeC'~j "Olog:a
lnous, al
MCP-2039
94
Table 27: World Recent Past, Current & Future Analysis for
Chitosan Consumption in Agrochemicals by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest o.FWorldMarkets
Independently Analyzed with Annulll Sales Figures
in Metric Tonsfor years 2007 through 2015
(Includes Corresponding Graph/Chart)
95
.86
89
92
.101
102
TransactIon' 420367195-19625
D2~e de!i'.-erec! : ..,S:2011
L,cersee Ms T: "lese
Corrp21ly
je Tecr'lo og a
nOJstr'c'
MCP2039
..104
Analysis.....
..
104
Analytics
......
Ill
. 104
.. ... 106
...106
107
A. Market
Analysis
........
III
...
.............. 111
Current & Future Analysis
.
....... 111
Chitosan Market by End-use.
Government Approves Use of Shellfish Waste in
......... 111
ChitinlChitosan
Production
B. Market
Analytics
........... 112
by Product Derivative
- Glucosamme,
112
I 13
J 14
Tcansacilon
420367195-19625
D?te Oe1i\lereo 7/'19,2011
Licensee
'v1s 10rnese
COlnpany
,nstltJto Nacional de Technologla
ndustnal
MCP-2039
15. JAPAN
117
A. Market
Analysis..............
.. 117
117
Applications
- Potential
Growth Segment
Analytics
117
117
118
..
.... 118
... 118
119
........................................................
A. Market
123
... 123
.. 123
.
125
126
127
A. Market
122
.... 123
124
17. ASIA-PACIFIC
............. 123
Analysis ..
Market Overview
Chitosan Market by End-use
121
Analysis
129
...
.129
.. 129
........ 129
.. 129
........ 129
.. ... 129
.. 130
130
Transaclion: 420367195-19625
D",1e ,jel'vered' 7/19/2011
l..ICerSee Ms Tornese
India
.
Export Scenario - Historic Perspective ....
Raw Materials for Chitin/Chitosan Being
Thrown Away...........
..
Thailand
..
Production Trends
.
B. Market
Analytics
MCP.2039
..
.
.
..
130
130
.. 131
.. .. 131
131
............................
132
..... 137
A. Market
............ 137
Analysis
.......... 137
Analytics..
..
....... 137
..137
138
133
138
133
139
135
MCP-2039
142
27. Kraeber
143
28. Kunpoong
144
29. Marinard
4. Bannawach
145
(India)
Inc. (USA)
I. Advanced
Biopolymers
2. Aexim Chemicals
AS (Norway)
Bio-Line
(Bangladesh)
of Chemical
Engineering
and
(USA)
7. CarboMer,
Limited Partnership
(Thailand).
.
12. Dalwoo-Chitosan
14. FabriChem,
BLS (Korea)
17. Golden-Shell
18. Guanyun
Bioscience
19. HaloSource,
170
..174
Development
176
... 177
Industry
Plant Corporation
SA (Belgium).......
202
(India)......................
203
... 204
204
39. Qingdao
205
40. Qingdao
Yunzhou
206
4 I. Rongcheng
Biochemistry
Luyang Chemical
42. Seafresh
Chitosan
43. Shanghai
Nicechem
45. Shangyu
207
207
.
208
... 210
... 210
211
178
180
181
Inc. (USA)
SO. V-Labs,
(Russia)
Sea Biochemical
Inc. (USA)....
212
... 213
........... 216
184
185
... 214
..186
195
.
182
194
194
183
193
.
.
177
(JBICHEM)
.
(Taiwan).
Medicare
193
.
Marine Bioengineering
...... 172
Co .. Ltd. (China)..................
And Technology
Chitosan
36. Pharmed
170
171
Inc. (USA)
25. Kitozyme
169
. .......... 174
Biochemical
Chitinor AS (Norway)......
Co., Ltd. (Russia)
.
and Technology
35. Oligopharm
ASA (Norway)
..... 169
(USA)
33. Navamedic
(India).
A/S (Denmark)
Inc. (USA)
..148
192
34. Novozymes
191
........ 152
9. Carmeda AB (Sweden)
190
Biotech (Canada)
.. 146
....... 150
Inc. (USA).
188
Industry
. 217
Aoxing Biotechnology
.
.
218
218
219